Analysis of HSCR patient exome sequence data using Zebrafish
使用斑马鱼分析 HSCR 患者外显子组序列数据
基本信息
- 批准号:8638444
- 负责人:
- 金额:$ 25.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:9q31AccountingAllelesAnimal ModelAntisense OligonucleotidesBiological ModelsCandidate Disease GeneChildChildhoodClinicalClinical DataCodeCollaborationsCollectionComplexCongenital MegacolonDNADNA SequenceDataDefectDevelopmentDiseaseEnhancersEnteralEnteric Nervous SystemEtiologyFemaleFishesGastrointestinal tract structureGene CombinationsGenesGeneticGenetic CounselingGenetic EpistasisGenetic ScreeningGenetic VariationGenomicsGoalsHereditary DiseaseHeritabilityHumanHuman GenomeIndividualIntestinesIntronsLive BirthMediatingMethodsMutateMutationNervous system structureNeuronsOrganismParentsPatientsPenetrancePilot ProjectsPopulationPredispositionProbabilityRecurrenceResourcesRiskRisk FactorsSamplingScientistSex CharacteristicsSex RatioSiblingsSyndromeTestingVariantWaardenburg-Shah syndromeZebrafishbasedisease phenotypeexomeexome sequencinggene discoverygenetic pedigreegenome-wide linkagehuman diseaseknock-downloss of functionmalemanmutantnervous system developmentnovelpositional cloningpublic health relevanceresearch study
项目摘要
PROJECT SUMMARY
The goal of this project is to demonstrate that the zebrafish can be used to rapidly determine the functional
significance of newly identified gene variants in Hirschsprung disease (HSCR) patients. HSCR is a pediatric
condition where the enteric nervous system (ENS) fails to form properly. The disease occurs once in every
5,000 live births and occurs both familially and sparodically. HSCR is a classic multifactorial genetic disorder,
and its genetic basis is only partly understood. So far, geneticists have identified 12 genes with mutations in
HSCR patients. Of these genes, ret accounts for >80% of all known mutations. However the genetic basis of
the disease in the vast majority of HSCR patients is unknown. Furthermore, there is a high degree of variability
in the penetrance of the disease phenotype associated with mutations in the known HSCR genes. Recent
studies have identified a ret susceptibility allele in an enhancer of intron 1 of the ret gene that appears to be a
significant risk factor in developing the disease but it is not sufficient to cause HSCR on its own.
We have developed the zebrafish as a model system to study ENS development. We have shown there
is a strong evolutionary conservation in the genes required for ENS development from zebrafish to man.
Nearly all of the known HSCR genes have been shown to be required for normal zebrafish ENS
development. Significantly, we have shown that antisense knockdown of the zebrafish orthologue of ret leads
to intestinal aganglionosis in the fish. In this exploratory proposal, we will utilize the zebrafish model system to
functionally analyze HSCR patients gene variants as a method to identify new causative HSCR genes. The
proposed study is based on a long-standing collaboration between the Shepherd and Hofstra labs and utilizes
the unique resources available to the labs (the collection of 400 Dutch HSCR patient DNA samples) and the
expertise found in both the Shepherd (Zebrafish ENS development) and Hofstra (Genetic basis of HSCR) labs.
Aim1: Identify gene variants in HSCR patients. There is a need for gene discovery in HSCR patients whose
disease is currently not assigned to a specific gene or genes. We will preform exome sequencing on a selected
group of HSCR patients who have the highest probability of having a strong loss of function coding mutation in
one or more genes not previously implicated in the disease.
Aim 2: Assess the functional significance of 10 selected HSCR exome identified genes in zebrafish.
We will clone and characterize the expression of zebrafish orthologues of the HSCR variant genes. We will
then use anti-sense oligonucleotides to assess the effects of these genes on zebrafish ENS development
either alone or in combination with ret mutations in order to test for epistasis.
The proposed Aims will identify new genes or gene combinations that cause HSCR. This will benefit
patients directly when they undergo genetic screening for the condition and will potentially offer scientists new
targets for the development of novel therapies to treat HSCR.
项目摘要
该项目的目标是证明斑马鱼可以用于快速确定功能
新发现的基因变异在先天性巨结肠(HSCR)患者中的意义。HSCR是一种儿科
肠神经系统(ENS)不能正常形成的情况。这种疾病每隔一段时间就会发生一次。
5,000例活产,家庭和零星发生。HSCR是一种典型的多因素遗传性疾病,
它的遗传基础也只是部分被了解。到目前为止,遗传学家已经确定了12个基因突变,
HSCR患者。在这些基因中,ret占所有已知突变的80%以上。然而,遗传基础
绝大多数HSCR患者的疾病是未知的。此外,
在与已知HSCR基因突变相关的疾病表型中,最近
研究已经在ret基因的内含子1的增强子中鉴定了ret易感性等位基因,
这是发展疾病的重要风险因素,但本身不足以引起HSCR。
我们已经开发了斑马鱼作为模型系统来研究ENS的发展。我们在那里展示了
是一个强大的进化保守的基因所需的ENS发展从斑马鱼到人。
几乎所有已知的HSCR基因都被证明是正常斑马鱼ENS所必需的
发展值得注意的是,我们已经表明,反义敲低斑马鱼的ret直向同源物,
肠道无神经节细胞症在这个探索性的建议中,我们将利用斑马鱼模型系统,
功能分析HSCR患者基因变异体作为鉴定新的致病HSCR基因的方法。的
拟议的研究是基于Shepherd和Hofstra实验室之间的长期合作,并利用
实验室可利用的独特资源(收集了400份荷兰HSCR患者DNA样本)和
Shepherd(斑马鱼ENS开发)和Hofstra(HSCR的遗传基础)实验室的专业知识。
目的1:确定HSCR患者的基因变异。需要在HSCR患者中发现基因,
疾病目前没有被分配到一个特定的基因或基因。我们将对选定的
HSCR患者组中具有最高可能性的HSCR患者具有较强的功能丧失编码突变,
一个或多个先前与疾病无关的基因。
目的2:对10个斑马鱼HSCR外显子组基因的功能进行分析。
我们将克隆和表征斑马鱼同源的HSCR变异基因的表达。我们将
然后使用反义寡核苷酸来评估这些基因对斑马鱼ENS发育的影响
单独或与RET突变组合以测试上位性。
拟议的目标将确定新的基因或基因组合,导致HSCR。这将有利于
患者直接当他们接受基因筛查的条件,并可能提供科学家新的
为开发治疗HSCR的新疗法提供了靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IAIN T SHEPHERD其他文献
IAIN T SHEPHERD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IAIN T SHEPHERD', 18)}}的其他基金
Development of the Zebrafish Enteric Nervous System
斑马鱼肠神经系统的发育
- 批准号:
7111725 - 财政年份:2004
- 资助金额:
$ 25.1万 - 项目类别:
Development of the Zebrafish Enteric Nervous System
斑马鱼肠神经系统的发育
- 批准号:
6953190 - 财政年份:2004
- 资助金额:
$ 25.1万 - 项目类别:
Development of the Zebrafish Enteric Nervous System
斑马鱼肠神经系统的发育
- 批准号:
7036409 - 财政年份:2004
- 资助金额:
$ 25.1万 - 项目类别:
Development of the Zebrafish Enteric Nervous System
斑马鱼肠神经系统的发育
- 批准号:
6870348 - 财政年份:2004
- 资助金额:
$ 25.1万 - 项目类别:
Development of the Zebrafish Enteric Nervous System
斑马鱼肠神经系统的发育
- 批准号:
7482198 - 财政年份:2004
- 资助金额:
$ 25.1万 - 项目类别:
Development of the Zebrafish Enteric Nervous System
斑马鱼肠神经系统的发育
- 批准号:
7281162 - 财政年份:2004
- 资助金额:
$ 25.1万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 25.1万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 25.1万 - 项目类别: